From: Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder
Effect | EQ-5D utility | OAB-5D utility | ||||
---|---|---|---|---|---|---|
β estimate | β SE a | P value b | β estimate | β SE a | P value b | |
Intercept | 0.940 | 0.0230 | <.0001 | 0.766 | 0.0085 | <.0001 |
Age | -0.001 | 0.0002 | 0.0006 | 0.0003 | 0.0001 | <.0001 |
Gender: female vs. male | -0.021 | 0.0063 | 0.0006 | 0.005 | 0.0024 | 0.0551 |
BMI | -0.003 | 0.0004 | <.0001 | -0.001 | 0.0002 | 0.0003 |
Previously treated with antimuscarinics | -0.019 | 0.0055 | 0.0006 | -0.017 | 0.0021 | <.0001 |
Micturitions level: 1 vs. 5 | 0.056 | 0.0057 | <.0001 | 0.088 | 0.0022 | <.0001 |
Micturitions level: 2 vs. 5 | 0.040 | 0.0052 | <.0001 | 0.055 | 0.0021 | <.0001 |
Micturitions level: 3 vs. 5 | 0.029 | 0.0051 | <.0001 | 0.035 | 0.0020 | <.0001 |
Micturitions level: 4 vs. 5 | 0.019 | 0.0051 | 0.0002 | 0.019 | 0.0020 | <.0001 |
Incontinence episodes level: 1 vs. 5 | 0.052 | 0.0052 | <.0001 | 0.076 | 0.0020 | <.0001 |
Incontinence episodes level: 2 vs. 5 | 0.037 | 0.0052 | <.0001 | 0.048 | 0.0020 | <.0001 |
Incontinence episodes level: 3 vs. 5 | 0.022 | 0.0054 | <.0001 | 0.025 | 0.0021 | <.0001 |
Incontinence episodes level: 4 vs. 5 | 0.011 | 0.0058 | 0.0481 | 0.012 | 0.0023 | <.0001 |
Study: SCORPIO vs. CAPRICORN | -0.019 | 0.0081 | 0.0174 | -0.012 | 0.0030 | <.0001 |
Study: ARIES vs. CAPRICORN | -0.008 | 0.0083 | 0.3409 | 0.004 | 0.0031 | 0.1984 |